Država: Austrija
Jezik: engleski
Izvor: HMA (Heads of Medicines Agencies)
tilmicosin 250 mg/ml
Huvepharma N.V.
QJ01FA91
Concentrate for oral solution
tilmicosin
Cattle Young, Chicken Broilers, Chicken Young, Pigs, Turkeys
2010-03-26
TILMOVET 250 MG/ML CONCENTRATE FOR ORAL SOLUTION Huvepharma NV Page 1 of 14 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS TILMOVET 250 MG/ML CONCENTRATE FOR ORAL SOLUTION Huvepharma NV Page 2 of 14 1. NAME OF THE VETERINARY MEDICINAL PRODUCT TILMOVET 250 MG/ML CONCENTRATE FOR ORAL SOLUTION _FOR PIGS, CHICKENS, TURKEYS _ _AND CATTLE (CALVES)_ (BE, BG, CZ, EL, HU, IE, NL, PL, RO, UK) TILMOVET 250 MG/ML CONCENTRADO EN SOLUCIÓN ORAL (ES) TILMOVET 250 MG/ML CONCENTRADO LIQUIDO PER USO ORALE (IT) TILMOVET 250 MG/ML SOLUTION BUVABLE (FR) TILMOVET 250 MG/ML LÖSUNG (AT) TILMOVET 250 MG/ML SOLUÇÃO ORAL (PT) TILMOVET VET, ORAL OPLØSNUNG (DK) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Tilmicosin: 250 mg per ml. Excipients For the full list of excipients: see section 6.1 3. PHARMACEUTICAL FORM Concentrate for oral solution Clear yellow to amber solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (broilers and pullets), turkeys, pigs and cattle (calves). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: For the treatment and prevention of respiratory infections associated with _Mycoplasma hyopneumoniae_, _Pasteurella multocida and Actinobacillus _ _pleuropneumoniae when the disease has been diagnosed at the herd level_. Chickens: For the treatment and prevention of respiratory infections in poultry flocks associated with _Mycoplasma gallisepticum and Mycoplasma synoviae when the disease has _ _been diagnosed at the herd level_. Turkeys: For the treatment and prevention of respiratory infections in turkey flocks associated with _Mycoplasma gallisepticum _and _Mycoplasma synoviae when t Pročitajte cijeli dokument
TILMOVET 250 MG/ML CONCENTRATE FOR ORAL SOLUTION Huvepharma NV Page 1 of 14 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS TILMOVET 250 MG/ML CONCENTRATE FOR ORAL SOLUTION Huvepharma NV Page 2 of 14 1. NAME OF THE VETERINARY MEDICINAL PRODUCT TILMOVET 250 MG/ML CONCENTRATE FOR ORAL SOLUTION _FOR PIGS, CHICKENS, TURKEYS _ _AND CATTLE (CALVES)_ (BE, BG, CZ, EL, HU, IE, NL, PL, RO, UK) TILMOVET 250 MG/ML CONCENTRADO EN SOLUCIÓN ORAL (ES) TILMOVET 250 MG/ML CONCENTRADO LIQUIDO PER USO ORALE (IT) TILMOVET 250 MG/ML SOLUTION BUVABLE (FR) TILMOVET 250 MG/ML LÖSUNG (AT) TILMOVET 250 MG/ML SOLUÇÃO ORAL (PT) TILMOVET VET, ORAL OPLØSNUNG (DK) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Tilmicosin: 250 mg per ml. Excipients For the full list of excipients: see section 6.1 3. PHARMACEUTICAL FORM Concentrate for oral solution Clear yellow to amber solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (broilers and pullets), turkeys, pigs and cattle (calves). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: For the treatment and prevention of respiratory infections associated with _Mycoplasma hyopneumoniae_, _Pasteurella multocida and Actinobacillus _ _pleuropneumoniae when the disease has been diagnosed at the herd level_. Chickens: For the treatment and prevention of respiratory infections in poultry flocks associated with _Mycoplasma gallisepticum and Mycoplasma synoviae when the disease has _ _been diagnosed at the herd level_. Turkeys: For the treatment and prevention of respiratory infections in turkey flocks associated with _Mycoplasma gallisepticum _and _Mycoplasma synoviae when t Pročitajte cijeli dokument